LONG-TERM INDAP THERAPY EFFECTIVENESS AND SAFETY IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
In total, 40 elderly patients with arterial hypertension (AH) were examined. Seventy percent received indap monotherapy (2,5 mg/d), and 30% – combined therapy (indap plus lisinopril). The follow-up period lasted for 12 months. At baseline and after the end of the treatment, all participants underwen...
Saved in:
Main Authors: | M. E. Statsenko, S. V. Belenkova, T. G. Shcherbakova, O. E. Sporova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2009-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1369 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organoprotection and quality of life in elderly hypertensive patients receiving indapamide treatment
by: M. E. Statsenko, et al.
Published: (2006-08-01) -
Arterial hypertension treatment effectiveness in elderly patients
by: M. E. Statsenko, et al.
Published: (2008-12-01) -
LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE
by: M. E. Statsenko, et al.
Published: (2016-01-01) -
Microcirculation in elderly patients with arterial hypertension
by: G. G. Efremushkin, et al.
Published: (2009-04-01) -
Large artery hemodynamics in elderly patients with arterial hypertension
by: G. G. Efremushkin, et al.
Published: (2010-04-01)